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The  complexity  of  the  list  of  enzymes,  factors,  and  receptors  synthesized  by 
mononuclear phagocytes suggests that they perform many functions in vivo. Recently 
monoclonal antibodies (mAb)a have been described which, when compared with other 
hemopoetically derived cells, recognize specific antigens on human or murine phag- 
ocytes (1-4). Although there is as yet little information about the cellular functions in 
which  the  recognized  antigenic  moieties  might  be  engaged,  their  expression  on 
monocytes and/or  macrophages  suggests  that  they participate  in hitherto  unrecog- 
nized activities of phagocytes. 
One of these monocyte antigens recognized by the mAb, UC45  (2), is the topic of 
the  present  report.  It will  be shown that  the  antigen  is well  known,  namely  fibrin. 
There have been a  number of reports linking immune responses and lymphoid cells 
with coagulation (5, 6). In particular, monocytes, when exposed to activated lympho- 
cytes or their  products  in  vitro,  are  able  to express  a  procoagulant  activity  (7-10). 
Monocytes are known to bear receptors for fibrin and fibrinogen  (11,  12); moreover, 
macrophages  recovered  from  guinea  pigs  undergoing  delayed-type  hypersensitivity 
reactions were covered with fibrin (13). This present report establishes that a subpop- 
ulation  of human  monocytes, when  exposed  to  plasma,  are  able  to  form on  their 
surfaces needle-like structures of fibrin. These needles have unique antigenic properties 
detected by the mAb UC45, which reacts with the a  chain of fibrin as it is found on 
monocytes, but very poorly with the amorphous network of the standard fibrin clot. 
Materials  and Methods 
Human Mono~ytes and Plasma.  Human monocytes from normal donors were prepared from 
peripheral blood mononuclear cells after Ficoll-Hypaque density (P -- 1.09) centrifugation and 
subsequent adherence to petri dishes  coated with microexudate from BHK cells  (2,  14). After 
removal from the BHK microexudate with  3 mM EDTA and centrifugation,  the cells  were 
resuspended in Dulbecco's modified Eagle's medium containing 5% fetal calf serum and allowed 
to adhere to  13-mm round glass coverslips,  usually for an overnight period unless otherwise 
specified.  These cells were >99% monocytes as assessed by generalized cytoplasmic staining for 
a-naphthyl acetate esterase (NSE) enzyme (15). 
The plasma used in the majority of the reported experiments consisted of the top layer of the 
Ficoll-Hypaque gradient  used to fractionate heparinized  or citrated blood. The plasma was 
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thus diluted -1:2 and was used within a  few days after preparation.  To induce fibers on the 
monocytes,  coverslips were  incubated  for  10  min  at  37°C  with  25  or  50 #1  of plasma.  The 
coverslips were  then  washed  thoroughly  in  phosphate-buffered  saline,  pH  7.4,  minus  Ca +2, 
Mg  +2 (PBS-A) before further treatment. 
Tissue Macrophages.  Lung macrophages from the uninvolved lungs of two Hodgkin's disease 
patients were isolated by adherence to microexudate coated plates (2,  14). These samples were 
a  gift from  Dr. John  Habeshaw,  St.  Bartholemew's Hospital,  London.  In a  similar manner, 
macrophages were prepared  from three samples of breast  milk (University College Hospital). 
Thymus tissue from two cardiac surgery patients (Institute of Child Health, London) and three 
pairs of tonsils (University College Hospital) were extensively teased, washed, and the macro- 
phages isolated as above. 
Antisera and Other Reagents.  UC45 hybridoma tissue culture medium was used except where 
otherwise noted. As UC45 is an IgM antibody, two other IgM mAb were used as controls. IIC3, 
which has specificity for the leech nervous system, was obtained  from Dr. Birgit Zipser (Cold 
Spring Harbor  Laboratory,  Cold Spring Harbor,  NY)  and T13,  which reacts with human  T 
cells, was obtained  from Dr.  Peter Beverley (UCH  Medical  School, London).  A  fourth IgM 
mAb, J 15, specifically reactive with platelets, was obtained from Dr. Andrew McMichael (John 
Radcliffe Hospital, Oxford). Unless otherwise specified, all mouse mAb were used undiluted in 
the form of tissue culture medium from the respective hybridoma cell lines. A rabbit antibody 
to human fibrinogen was obtained from Dr. Patrick Gaffney (Institute for Biological Standards, 
London). It was used at a dilution of 1:300.  Normal rabbit serum (1:300) was used as a control. 
Human fibrinogen (huF) was obtained from Miles Laboratories, Elkhart,  IN (code 82-311, lot 
A0.21).  Human fibrin was obtained from the plasma of a  single individual  (MF) by freezing, 
then thawing partially clottedplasma. The resulting flocculant material was washed extensively 
in  PBS-A and  used as  a  source of fibrin after analysis  by sodium  dodecyl  sulfate  (SDS)  gel 
electrophoresis. This procedure was adapted  from a  simple method for fibrinogen purification 
(17). 
Indirect Immunofluorescence.  In general, monocytes bearing fibers were tested as fixed prepa- 
rations. Thus, coverslips were fixed for 5 min in 3.7% formaldehyde in PBS-A, rinsed in PBS-A 
and water, and extracted with acetone at -20°C  for 5 min. After further rinsing, 20 p~l of the 
required antibody was added to the coverslip for 20 min at 37°C. After washing three times in 
PBS-A, 20/~1 of the second antibody, either rhodamine-conjugated  goat anti-mouse immuno- 
globin  (Rd  GaMIg)  or  fluorescein-conjugated  goat  anti-rabbit  immunoglobulin  (F1  GaRIg) 
(N. L. Cappel Laboratories, Cochranville, PA) was added and a second incubation carried out 
for 20 min at 37°C. Both "second layer" antibodies were used at a dilution of 1:20. After three 
further washes, the coverslips were inverted over a  drop of Gelvatol (Monsanto Co., St. Louis, 
MO) and visualized by epifluorescence microscopy. 
In  "double  labeling"  experiments,  the  mouse  monoclonal  antibodies  were  added  either 
together  with  the  rabbit  anti-huF  antibody  or  normal  rabbit  serum  or  mouse,  and  rabbit 
antibodies were added consecutively with a 20-min incubation for each antibody. Controls were 
done  to  make  certain  that  neither  Rd  GaMIg  or  F1  GaRIg reacted  with  the  inappropriate 
immunoglobulin. 
Preparation of  Monocyte Fibers.  Large coverslips (25-mm) containing -2 X  105 monocytes were 
incubated  with 200/~1  of fresh plasma  (1:2 dilution)  at 37°C. An equal number of coverslips 
containing monocytes but no plasma and coverslips containing plasma but no monocytes served 
as controls. After 20 min, the coverslips were carefully washed three times in PBS-A and then 
gently scraped with a rubber policeman. The cell and fiber mixture was then centrifuged for 5 
min at 80 g, which separated  the fiber "nets" from cells and any remaining plasma proteins. 
The resulting pellets were dissolved in  SDS gel sample buffer before storing at  -20°C.  The 
supernatants  were also stored at -20°C. 
Protein Transfer to Nitrocellulose Paper (Western Blotting).  Samples  of huF,  fibrin,  monocyte 
fibers, and a  mock fiber preparation  from monocytes without fibers were subjected to SDS gel 
electrophoresis, followed by transfer to nitrocellulose paper (0.45-/~m  pore size; Millipore Corp., 
Bedford,  MA)  following the  procedures  described  by Towbin  et  al.  (18).  One nitrocellulose 
strip was immediately stained with amido black and the others were incubated  for 2 h  in 3% 
bovine serum albumin (BSA)/PBS-A. These nitrocellulose strips were then incubated for 1 h at NANCY HOGG  475 
room temperature with 2 ml of either diluted tissue culture medium containing mAb UC45 
(1:5), mAb 11C3 (1:5), rabbit anti-F serum (1:20), or normal rabbit serum (1:20). The dilutions 
were done in 3% BSA. The strips were then washed four times over the course of one hour with 
PBS-A and were incubated for a second hour in either 125I-goat anti-mouse immunoglobulin 
antibody or 125I-goat anti-rabbit  immunoglobulin antibody, kindly provided by Dr. Jim Lin 
and Dr. Fumio Matsumura (Cold Spring Harbor Laboratory). Both iodinated antibodies were 
used at ~2 ×  106 cpm/ml of 3% BSA in PBS-A. The strips were finally washed in PBS-A five 
times over the course of several hours. The strips were blotted dry and analyzed by autoradiog- 
raphy. 
Results 
Plasma Induces Production of Fibers around Monocytes.  In a previous report (2), the IgM 
mAb UC45 was shown to react with needle-like projections found on a  proportion of 
peripheral blood mononuclear cells which adhered to glass. These cells were identified 
as NSE-positive monocytes. In the present  study it was found that when monocytes 
were  purified  by fractionation  on microexudate-coated  petri  dishes  (14),  the  fibers 
were removed from the cells.  If these purified monocytes (>99% NSE)  were allowed 
to readhere to glass and were then treated with human plasma, then needles or fibers 
were formed on a proportion of the cells. These are shown in Fig.  1 A, and the reaction 
of the fibers with UC45 is shown in Fig.  1 B. Reaction with a  control IgM antibody, 
11C3, was negative. The percentage of fiber-making monocytes ranged from 8 to 25% 
with an average of 18 -  8% using cells obtained  from  18 infrequently  bled donors. 
These  percentages  were obtained  from monocytes kept  in  culture  overnight  before 
treating  with  plasma.  If the  monocytes were  treated  within  15  min  after  isolation, 
usually  1-5%  of the  cells  made  fibers.  4  h  of tissue  culture,  however, increased  the 
percentage to a  maximum.  A  similar percentage of monocytes kept  in suspension in 
polycarbonate tubes also made fibers after 4 h  at 37°C, indicating that adherence to 
a substrate was not necessary. Samples kept at 4°C did not make fibers. 
In our previous study, 80% of monocytes were found to be UC45 positive (2). Cells 
were obtained from a group of frequently bled donors (50-100 ml/wk). It is of interest 
to know whether the increase in proportion of monocytes making fibers is related  to 
the frequent phlebotomy. 
Monocyte Fibers Labeled with Antibody to Fibrinogen.  Fiber-bearing  monocytes were 
tested  with  a  rabbit  antibody  to  huF  (dilution  1:300)  and  a  positive  reaction  was 
obtained.  Cultures  of fixed monocyte fibers are shown simultaneously  labeled  with 
both  UC45  (Fig.  2A)  and  rabbit  antibody  to  huF  (Fig.  2B).  The  two  antibodies 
coincidentally label the monocyte fibers,  strongly indicating that  fibrinogen-related 
molecules form at least part of the monocyte fibrous needle structure. 
To determine whether the huF and UC45 antigens might be present  on the same 
molecule or at  least  spatially close on the  fiber structure,  an  antibody competition 
experiment was done in which an attempt was made to block the binding of UC45 by 
rabbit anti-huF serum. Preincubation of fibers with the rabbit  antiserum ranging in 
dilution from 1:25 to 1:300 did not alter the fluorescence intensity of UC45 staining. 
This suggested that the UC45 and huF antigens were either on different  molecules, 
well  separated  on the same molecule,  or that  the rabbit  anti-huF  antibody did not 
contain specificities directed toward the UC45 antigen. 
Fig. 3 presents a comparison of the binding to conventional plasma fibrin of rabbit 
anti-huF serum UC45 and control antibodies.  The fibrin was formed by incubating 476  MONOCYTES  AND  FIBRIN 
FIG.  i.  A human monocyte displaying needle-like projections formed after a  10-min incubation at 
37°C  with  25  #1  fresh  human  plasma  (1:2)  shown  by  phase  microscopy  (A)  and  fluorescence 
rfiicroscopy (B) after reaction with monoclonal antibody UC45. Bar =  l0/tm. Fie.  2.  A  prefixed sample of human monocytes double labeled with rhodamine-positive UC45 
monoclonal antibody (A) and fluoreseein-positive rabbit anti-fibrinogen serum (B), phase micros- 
copy (C). Note the complete overlap in rhodamine- and fluoreseein-positive labeling of figures.  Bar 
10/tm. 
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Fic.  4.  Proteins  reacting with UC45 and rabbit  anti-fibrinogen serum after transfer from 10% 
SDS acrylamide gel to nitrocellulose paper  (18). Samples of human  fibrinogen (a), fibrin (b), 
monocyte fibers (c), and a mock fiber preparation  from monocytes with no fibers (d) are shown, 
stained with amido black (A), reacted with UC45 (B), 11C3 (C), rabbit anti-fibrinogen serum (D), 
and normal rabbit serum (E). The molecular weight markers used were: myosin heavy chain, 200 
kd; fl-galactosidase, 116.5 kd; phosphorylase a, 94.5 kd; bovine serum albumin, 68 kd; ovalbumin, 
45 kd; carbonic anhydrase, 30 kd. Bar ~  10/~m. 
50 #1 of citrated  plasma with  2.5  U  bovine thrombin  for  10 min at  37°C.  Whereas 
rabbit  anti-huF reacts strongly with  fibrin  (Fig. 3 B), the UC45 reaction  (Fig. 3 E)  is 
extremely  weak.  Fibrin  formed by incubation  of heparinized  plasma  with  reptilase 
gave  similar  results.  Thus,  the  antigen  detected  by  mAb  UC45  is  either  weakly 
represented or inaccessible on conventional fibrin. 
UC45 Reacts with the a  Chain of Fibrinogen and Fibrin.  In Fig. 4, samples of huF  (a), 
fibrin  (b), isolated monocyte fibers (c), and a  mock fiber preparation from monocytes 
with no fibers (d) were reacted with UC45 (B), rabbit anti-huF serum (D), and control 
antibodies  (C,  E)  by  the  protein  or  Western  blotting  technique  as  described  by 
Towbin  et  al.  (18).  First,  it  is  evident  that  the  monocyte  fiber  pattern  is  almost 
identical to that of fibrin. Second, UC45 reacts very strongly with the a-chain banding 
pattern  of huF,  fibrin,  and monocyte fibers.  A  second strongly staining band of 180 
kilodahons (kd) is seen in the fibrin sample (track b). This is in the correct position to 
be an a  chain trimer  (19). There is more faintly UC45-reactive material  in the fl and 
y  chain  regions.  The  control  IgM  mAb,  11C3~  gives  no  reaction.  The  pattern  of 
reactivity with rabbit  anti-F serum shows labeling of a, fl, and y  chains and y chain 
dimers  (100 kd), which are characteristic of fibrin  (19) and are most strongly labeled 
in the fibrin and monocyte fiber tracks. 
In  a  previous  report,  it  was  noted  that  UC45  reacted  with  a  45-kd  protein  (2), 
which would  seem  to be in  conflict with  the  reaction  of UC45  with  the 66 kd  Aa- 
chain  of fibrin(ogen).  The  explanation  is  that,  previously,  the restricted  activity of 
UC45  for  monocytes  (and  neurons)  was  determined  by  using  immunofluorescent 
techniques on intact viable cells. When cells were subsequently permeabilized,  it was 
found that UC45 reacted with mitochondria of all cells tested (unpublished).  Work is 
in progress to determine whether the previously detected 45-kd entity is a  mitochon- 
drial protein or an Aa-chain cleavage product. 
Blocking Fiber Production with  UC45 Monoclonal Antibody.  It was next  asked whether FIG.  5.  A prefixed sample of monocytes and platelets (A) double labeled with fluorescein-positive 
rabbit anti-fibrinogen serum (B) and rhodamine-positive monoclonal antibody, J15, which specifi- 
cally reacts with platelets (C). See arrows. Bar =  10 btm. 
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incubation of monocytes or plasma with UC45 would have an effect on the ability of 
monocytes to make fibers. Either T13 ascitic fluid or UC45  ascitic fluid was prein- 
cubated with plasma before addition to monocytes. Fiber production was assessed by 
labeling the cells with UC45 or rabbit anti-huF serum. Preincubation with T 13 aseitic 
fluid  gave the  usual  fiber pattern,  whereas  preincubation  with  UC45  ascitic  fluid 
completely blocked  fiber  formation  (data  not  shown).  The  reverse  experiment  in 
which monocytes were preincubated with UC45 or T 13 ascitic fluid had no effect on 
fibrin formation. This result suggests that the UC45  antigen  plays some role in the 
polymerization  of  fibrinogen  by  monocytes  rather  than  acting  at  a  site  on  the 
monocyte membrane. 
Although  the UC45  antigen was not  easily detected  on extraeellular fibrin  (Fig. 
3E),  it  was  of  interest  to  know  whether  the  UC45  mAb  could  also  affect  the 
polymerization of this type of fibrin as assessed by the thrombin-time test. Accordingly, 
experiments were done parallel to the monocyte-blocking experiments using the same 
plasmas. The effect on the thrombin time was noted after addition  of 0.1  ml saline 
containing 5 U  of bovine thrombin (Diagnostic Reagents Ltd., Thame, England)  to 
0.2 ml of mAb-treated plasma. When the incubation contained 50/~1 of T13, opacity 
began  at  17  s,  clot  formation  at  19  s,  and  retraction  by  24  s.  These  times  were 
comparable to a  reaction to which no antibody had been added. When 50 ~1 UC45 
was contained in the reaction, opacity began at  10 s, clot formation between  16 and 
22  s, and retraction by 32  s. A  similar time sequence  of clotting was seen in  seven 
similar experiments that included the treatment of heparinized plasma with reptilase. 
Therefore,  although  UC45  did  perturb  clot  formation  through  initially  hastening 
then protracting the process, it did not prevent it from occurring. 
Platelets Play No Role in Fiber Formation.  It was posible that platelets were associated 
with  the  formation  of fibrin  on  the  monocytes.  That  they  were  not  involved  in 
monocyte fiber formation was determined in the following way. First, plasma spun at 
14,000  g  to  pellet  platelets  still  readily  caused  fiber  formation.  Second,  platelets 
adhering to monocytes are for the large part gone after an overnight incubation at a 
time  when  monocytes  make  fibers  with  facility.  Third,  the  remaining  platelets, 
detected with mAb J15 are scattered on the coverslips in a random fashion (Fig. 5 C) 
and  are not  associated in  any significant  way with  the  fiber-producing  monocytes 
labeled with rabbit anti-huF serum  (Fig.  5 B).  Fig.  5 was selected for the unusually 
large number of platelets surrounding the monocyte (Fig. 5 A). More frequently, no 
platelets were seen in the vicinity of fiber-bearing monocytes. 
Lack of Ability  of Many  Tissue Macrophages to Cause Fibrin Formation.  Macrophages 
isolated from lung,  thymus, and breast milk failed to cause fibrin needle formation 
when incubated with plasma for periods of time from 2 h  to overnight in culture. In 
contrast, microexudate-adherent tonsil cells were active in fibrin formation. Extensive 
networks of UC45-positive fibrin enveloped the majority of tonsil cells that were 90% 
NSE  positive.  The  morphology of the  tonsil  cells  indicated  that  this  population 
consisted of cells of monocyte size (31 __. 11%) as well as larger tissue macrophages (69 
+  11%). Because of the extensive nature of the UC45-positive network, it was difficult 
to be certain whether the fibrin formation initiated only from the smaller monocytic 
cells  or  whether  the  larger  macrophages  also  participated.  However,  in  a  typical 
experiment, when plasma was added  to the cells, 68  +  1% of tonsil cells were also 
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Discussion 
The purpose of this study was to determine the antigenic and chemical nature of 
peculiar needle-like fibers that form around substrate-attached human monocytes in 
culture when they are exposed to plasma for as short a  time as  15 s (Fig.  1). Several 
lines of evidence indicate that the major component of these needles is fibrin and that 
the UC45 mAb reacts with the a  chain of this monocyte fibrin. However, there are a 
number of observations that suggest that the fibrin comprising the monocyte needles 
may differ from that found in the conventional fibrin clot. First, fibrin clots label very 
poorly with UC45 but very well with rabbit anti-huF serum (Fig.  3), suggesting that 
the  UC45  antigen  which  is  prominently  displayed  on  monocyte fibrin  is  weakly 
expressed or inaccessible on fibrin  clots.  Furthermore,  there was no competition by 
the polyclonal rabbit anti-huF serum for binding to the antigenic site recognized by 
the monoclonal antibody, UC45, as would be expected if both reacted with the same 
molecular species.  This  would suggest  that  the  UC45  antigen  on monocyte fibers, 
which was obviously immunogenic in the mouse, was either not immunogenic or not 
prominently expressed on human huF against which the rabbit antiserum was raised. 
These observations strongly indicate that the UC45 antigen present on a  chain may 
be  characteristic  of the  special  needle-like  fibrin  formed  by  monocytes and  only 
sparsely represented or inaccessible on extracellular fibrin and nonpolymerized huF. 
The fact that UC45 reacts with denatured Aa chain in the Western blotting procedure 
suggests  that  the  antigen  may  be  cryptic  in  native  fibrinogen  but  exposed  in  an 
altered structure of fibrin in the monocyte needle. 
There are several possible sources for the huF that is polymerized to form the fibrin 
needles.  Macrophages bear receptors for huF and fibrin (11,  12), which indicates that 
the binding of huF from plasma to these receptors might initiate the needle-making 
process.  However,  one  might  speculate  that  macrophages  themselves  contain  huF 
perhaps in granule form, as do platelets, which are present in plasma unless removed. 
Platelets,  which  have  a  crucial  role  in  vascular clotting,  bind  huF  when  they are 
activated, contain huF in c~ granules, and adhere to freshly isolated monocytes. It was 
therefore possible that platelets bound to monocytes were responsible for the reported 
observations.  This  seems  unlikely  because,  at  a  time  when  monocytes very avidly 
made  their  needle-like  fibrin,  a  mAb specific  for platelets,  J15,  detected  very  few 
platelets associated with monocytes, either on them or nearby (Fig.  5),  and platelet- 
free plasma induced macrophage fiber formation. That  the huF did not come from 
the  monocytes themselves but  from plasma  is  suggested  by the  ability of UC45  to 
block fiber formation when co-incubated with  plasma,  but  not when preincubated 
with  monocytes alone.  Moreover,  after  the  monocyte isolation  procedure,  neither 
viable nor permeabilized ceils  demonstrated a  reaction with  rabbit  anti-huF serum 
by immunofluorescent techniques  (data  not  shown).  The blocking experiment  also 
suggests that  the  UC45  antigen  plays a  role in  the polymerization resulting in  the 
monocyte needles.  Although the antigen is poorly detected on conventional plasma 
fibrin, it was of interest to observe that, at the highest concentrations of antibody, the 
thrombin and reptilase times were prolonged, but clot formation was not prevented, 
again suggesting that the antigen plays a special role in monocyte fibrin. 
There is heterogeneity amongst monocytes in their ability to make fibrin needles. 
In the present study, in which cells were obtained from  18 infrequently bled donors, NANCY HOGG  483 
the percentage of fibrin-making monocytes ranged from 8 to 25%, with an average of 
18 +  8%. Although a proportion of the monocytes were able to make fibrin as soon as 
they were put  into culture,  the final percentage was reached between 4  and 6  h  of 
culture and then did not alter. This did not depend on the adherence of monocytes 
to a substrate as cells maintained in suspension were also able to make fibrin. Thus it 
appears that a  distinct subpopulation of monocytes has the ability to form fibrin on 
their  membranes.  Whether  the  same  monocytes  and  macrophages  also  produce 
plasminogen activator, which leads to fibrinolysis, is unknown. It could be speculated 
that  this  subpopulation  of fibrin-producing  monoeytes is  detected  because  it  lacks 
plasminogen  activator  and  is  thus  able  to  retain  fibrin,  whereas  the  majority  of 
monocytes may have it removed immediately. 
Although  two  other  studies  have  reported  (13,  20),  using  immunofluorescent 
techniques, the presence of fibrin on phagocytes, the more widely observed phenom- 
enon has been the induction of a procoagulant activity in phagocytes by exposure to 
activated  lymphocytes and  their  products  (7-10).  Although  this  question  was  not 
addressed  in  this  study,  there  was  sufficient  opportunity  for  interaction  between 
monocytes and lymphocytes during the purification procedure, which included a  30- 
min incubation at 37°C. Procoagulant activity is also increased after 4-6 h of culture 
and has been shown to be dependent  on new RNA and protein synthesis  (21). This 
coincidence  of timing  in  activation  of procoagulant  activity,  thought  to  be  tissue 
factor,  the  first  event  of the  extrinsic  pathway  of coagulation,  and  the  ability  of 
monocytes to make fibrin, which  is the  final event of coagulation,  suggest  that  the 
entire extrinsic pathway of coagulation is being activated in monocytes. None of the 
other factors involved in the extrinsic pathway, factors VII, X, V, or II, have yet been 
reported  to  be synthesized  by human  monoeytes or macrophages, either before or 
after in vitro activation. 
These observations raise the question of the possible role of coagulation in immune 
responses, particularly in tissue inflammation, where fibrin deposition is observed (5, 
6). The evidence presented in this paper suggests that activated circulating monocytes 
are the responsible cells.  More mature macrophages from lung,  thymus, and breast 
milk did not have this capability, but a much higher proportion of phagocytes (70%) 
from inflamed tonsils were involved in  fibrin formation. This may be the result of 
either a selective migration of cells with this capacity to the tonsil or in situ activation 
of circulating monocytes. A  further observation linking fibrin formation with mono- 
cyte activation comes from the observation that acute monocytic leukemia cells, tested 
by immunofluorescence without any prior in vitro manipulation reacted with UC45 
(22). 
The in vivo effect of fibrin formation remains obscure. Hopper et al.  (13)  suggest 
that the induction ofprocoagulant activity is accompanied by a decrease in the ability 
of macrophages to respond to chemotactic agents. This would cause them to remain 
localized  at  the  site of tissue  damage, possibly phagocytosing debris.  Furthermore, 
fibrin serves as a substrate for fibronectin, which precedes the appearance of collagen 
in  the  remodeling  of loose  connective  tissue  (23).  Fibrin  is  covalently  linked  to 
fibronectin by factor XIII (24), and both fibronectin and factor XIII are synthesized 
by phagocytes (25,  26).  This evidence suggests that the laying down of fibrin is the 
initiating event in tissue repair. Although the role of fibrin in in vivo activities other 
than blood clotting remain speculative, it is hoped that  identification  of the UC45 484  MONOCYTES  AND  FIBRIN 
antigen  will  provide  a  means  of assessing  the  importance  of fibrin  generated  by 
monocytes in physiological events. 
Summary 
Purified populations of human monocytes (>99%  monocytic) contain a  subpopu- 
lation  of cells  (8-20%)  that  will  surround  themselves  with  a  radial  array of needles 
within  15 s after exposure to plasma.  The needles are composed of fibrin as demon- 
strated  by  gel  electrophoresis  of  isolated  needles  and  by  their  reaction  with  a 
monoclonal antibody, UC45, that is specific for the a  chain of fibrin. The addition of 
UC45 antibody to plasma inhibits the formation of the fibrin needles by monocytes, 
suggesting that  the recognized antigen  is important  for polymerization.  In contrast, 
UC45 binds  weakly to conventional  plasma  fibrin  and does not prevent  clotting of 
plasma  although  the  process is  prolonged.  Thus,  the  UC45  antigen  is  more promi- 
nently represented or more accessible on monocyte fibrin. At least  1% of the monocytes 
were  able  to  form  fibers  at  the  earliest  time  that  they  could  be  tested.  A  greater 
proportion  developed  this  ability between  2  and 6  h  in culture.  Macrophages  from 
lung,  thymus,  and  breast  milk,  when  incubated  for similar  periods  of time,  do not 
form fibrin  needles.  However, phagocytes from tonsils were extremely active in this 
respect.  It is speculated  that  monocytes may be induced to express  fibrin  as part  of 
their activities in inflammatory lesions. 
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